Hematology/Oncology

Aziz N, LaBelle E, Jamieson BD, Mimiaga MJ, Detels R. Comparison of basic lymphocyte phenotype results between a diagnostic and a research laboratory. Lab Med.[...]

By sjmartinez • November 22, 2024

Cao M, Ramezani R, Katakwar VK, Zhang W, Boda D, Wani M, Naeim A. Developing remote patient monitoring infrastructure using commercially available cloud platforms. Front[...]

By sjmartinez • November 21, 2024

Yi JC, Ballard S, Walsh C, Friedman DN, Ganz PA, Jacobs LA, Partridge AH, Mitchell SA, Leisenring WM, Syrjala KL, Baker KS. INteractive survivorship program[...]

By sjmartinez • November 20, 2024

Bitar R, Salem R, Finn R, Greten TF, Goldberg SN, Chapiro J. Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma. Radiology. 2024 Nov;313(2):e232875. doi:[...]

By sjmartinez • November 20, 2024

Oh MS, Dumitras C, Salehi-Rad R, Tran LM, Krysan K, Lim RJ, Jing Z, Tappuni S, Lisberg A, Garon EB, Dubinett SM, Liu B. Characteristics[...]

By sjmartinez • November 20, 2024

Patel N, Karanth R, Isaacs DJ, Cohen J, Wong DJ, Delshad SD. A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination[...]

By sjmartinez • November 20, 2024

Burley N, Lee Y, Liu L, Gangi A, Nasseri Y, Atkins K, Zaghiyan K, Murrell Z, Osipov A, Hendifar A, Hitchins M, Gong J. ctDNA-guided[...]

By sjmartinez • November 18, 2024

Sharma R, Orogian A, Garcia-Pacheco R, Trang T, Clarke M, Stull W, Kim S. Primary Thyroid Lymphoma: A Rare Diagnosis Treated With Polatuzumab Vedotin. J[...]

By sjmartinez • November 17, 2024

Mowery YM, Ballman KV, Hong AM, Schuetze SM, Wagner AJ, Monga V, Heise RS, Attia S, Choy E, Burgess MA, Bae S, Pryor DI, Van[...]

By sjmartinez • November 17, 2024

Gu Y, Ly A, Rodriguez S, Zhang H, Kim J, Mao Z, Sachdeva A, Zomorodian N, Pellegrini M, Li G, Liu S, Drakaki A, Rettig[...]

By sjmartinez • November 14, 2024